RA Capital Management, L.P. 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 9,710,428 16.100% | -396,972 (-3.93%) | Filing |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 10,107,400 17.500% | 140,228 (+1.41%) | Filing |
| 2023-04-10 5:00 pm Purchase | 2023-04-06 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 9,967,172 17.400% | 3,009,993 (+43.26%) | Filing |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 6,957,179 12.200% | -610,721 (-8.07%) | Filing |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 7,567,900 13.300% | 1,702,562 (+29.03%) | Filing |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 5,865,338 10.900% | 46,476 (+0.80%) | Filing |
| 2020-09-10 4:29 pm Purchase | 2020-03-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 5,818,862 10.900% | 1,633,520 (+39.03%) | Filing |
| 2020-02-14 4:34 pm Purchase | 2019-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 4,185,342 8.800% | 52,900 (+1.28%) | Filing |